Tobacco smoking and intestinal metaplasia: Systematic review and meta-analysis

Digestive and Liver Disease

Volumn 46, Issue 11, 2014, Pages 1031-1037

  Morais, Samantha ^a   Rodrigues, Sandra ^a   Amorim, Liliana ^a   Peleteiro, Bárbara ^a,b   Lunet, Nuno ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b University of Porto   (Portugal)

Author keywords

Meta analysis; Precancerous conditions; Smoking; Stomach neoplasms

Indexed keywords

ARTICLE; CORRELATIONAL STUDY; FIRST DEGREE RELATIVE; GASTROINTESTINAL SYMPTOM; HISTOLOGY; HUMAN; INTESTINE METAPLASIA; META ANALYSIS; RISK FACTOR; SENSITIVITY ANALYSIS; SMOKING; STOMACH BIOPSY; STOMACH CARCINOGENESIS; SYSTEMATIC REVIEW; ADULT; ADVERSE EFFECTS; AGE DISTRIBUTION; AGED; CONFIDENCE INTERVAL; FEMALE; INTESTINAL NEOPLASMS; MALE; METAPLASIA; MIDDLE AGED; PATHOLOGY; PORTUGAL; PRECANCEROUS CONDITIONS; PREVALENCE; PROGNOSIS; RISK; RISK ASSESSMENT; SEX RATIO; STOMACH NEOPLASMS; SURVIVAL RATE;

ADULT; AGE DISTRIBUTION; AGED; CONFIDENCE INTERVALS; FEMALE; HUMANS; INTESTINAL NEOPLASMS; MALE; METAPLASIA; MIDDLE AGED; ODDS RATIO; PORTUGAL; PRECANCEROUS CONDITIONS; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; SEX DISTRIBUTION; SMOKING; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 84908161195     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2014.08.034     Document Type: Article

References (70)

1. GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012; 2012. Available at: . http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx.
2. Peleteiro B, Severo M, La Vecchia C, et al. Model-based patterns in stomach cancer mortality worldwide. European Journal of Cancer Prevention [E-pub ahead of print]. doi:10.1097/CEJ.0b013e328364f2b6.
3. Ferro A., Peleteiro B., Malvezzi M., et al. Worldwide trends in gastric cancer mortality (1980-2011), with predictions to 2015, and incidence by subtype. European Journal of Cancer 2014, 50:1330-1344.
4. Wu H., Rusiecki J.A., Zhu K., et al. Stomach carcinoma incidence patterns in the United States by histologic type and anatomic site. Cancer Epidemiology, Biomarkers and Prevention 2009, 18:1945-1952.
5. Camargo M.C., Anderson W.F., King J.B., et al. Divergent trends for gastric cancer incidence by anatomical subsite in US adults. Gut 2011, 60:1644-1649.
6. Koizumi Y., Tsubono Y., Nakaya N., et al. Cigarette smoking and the risk of gastric cancer: a pooled analysis of two prospective studies in Japan. International Journal of Cancer 2004, 112:1049-1055.
7. Santibanez M., Alguacil J., de la Hera M.G., et al. Occupational exposures and risk of stomach cancer by histological type. Occupational and Environmental Medicine 2012, 69:268-275.
8. Ekstrom A.M., Serafini M., Nyren O., et al. Dietary quercetin intake and risk of gastric cancer: results from a population-based study in Sweden. Annals of Oncology 2011, 22:438-443.
9. Peleteiro B., Lopes C., Figueiredo C., et al. Salt intake and gastric cancer risk according to Helicobacter pylori infection, smoking, tumour site and histological type. British Journal of Cancer 2011, 104:198-207.
10. Correa P., Haenszel W., Cuello C., et al. A model for gastric cancer epidemiology. Lancet 1975, 2:58-60.
11. Peleteiro B., La Vecchia C., Lunet N. The role of Helicobacter pylori infection in the web of gastric cancer causation. European Journal of Cancer Prevention 2012, 21:118-125.
12. IARC Tobacco smoke and involuntary smoking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 2004, 83:1-1438.
13. Gonzalez C.A., Sala N., Capella G. Genetic susceptibility and gastric cancer risk. International Journal of Cancer 2002, 100:249-260.
14. Riboli E., Norat T. Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. American Journal of Clinical Nutrition 2003, 78:559s-569s.
15. Vincenzi B., Patti G., Galluzzo S., et al. Interleukin 1beta-511T gene (IL1beta) polymorphism is correlated with gastric cancer in the Caucasian population: results from a meta-analysis. Oncology Reports 2008, 20:1213-1220.
16. Ladeiras-Lopes R., Pereira A.K., Nogueira A., et al. Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes and Control 2008, 19:689-701.
17. Mesquita P., Raquel A., Nuno L., et al. Metaplasia-a transdifferentiation process that facilitates cancer development: the model of gastric intestinal metaplasia. Critical Reviews in Oncogenesis 2006, 12:3-26.
18. Marsman W.A., Tytgat G.N., ten Kate F.J., et al. Differences and similarities of adenocarcinomas of the esophagus and esophagogastric junction. Journal of Surgical Oncology 2005, 92:160-168.
19. Peleteiro B., Cavaleiro-Pinto M., Barros R., et al. Is cardia cancer aetiologically different from distal stomach cancer. European Journal of Cancer Prevention 2011, 20:96-101.
20. Correa P., Piazuelo M.B., Wilson K.T. Pathology of gastric intestinal metaplasia: clinical implications. American Journal of Gastroenterology 2010, 105:493-498.
21. Dinis-Ribeiro M., Areia M., de Vries A.C., et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Virchows Archiv 2012, 460:19-46.
22. de Vries A.C., Haringsma J., de Vries R.A., et al. Biopsy strategies for endoscopic surveillance of pre-malignant gastric lesions. Helicobacter 2010, 15:259-264.
23. Zullo A., Hassan C., Romiti A., et al. Follow-up of intestinal metaplasia in the stomach: when, how and why. World Journal of Gastrointestinal Oncology 2012, 4:30-36.
24. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002, 21:1539-1558.
25. Sterne J.A., Gavaghan D., Egger M. Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. Journal of Clinical Epidemiology 2000, 53:1119-1129.
26. Nomura A., Yamakawa H., Ishidate T., et al. Intestinal metaplasia in Japan: association with diet. Journal of the National Cancer Institute 1982, 68:401-405.
27. Chooi E.Y., Chen H.M., Miao Q., et al. Chronic atrophic gastritis is a progressive disease: analysis of medical reports from Shanghai (1985-2009). Singapore Medical Journal 2012, 53:318-324.
28. Tatsuta M., Iishi H., Okuda S. Effect of cigarette smoking on extent of acid-secreting area and intestinal metaplasia in the stomach. Digestive Diseases and Sciences 1988, 33:23-29.
29. Kneller R.W., You W.C., Chang Y.S., et al. Cigarette smoking and other risk factors for progression of precancerous stomach lesions. Journal of the National Cancer Institute 1992, 84:1261-1266.
30. Ohkuma K., Okada M., Murayama H., et al. Association of Helicobacter pylori infection with atrophic gastritis and intestinal metaplasia. Journal of Gastroenterology and Hepatology 2000, 15:1105-1112.
31. Nakamura M., Haruma K., Kamada T., et al. Cigarette smoking promotes atrophic gastritis in Helicobacter pylori-positive subjects. Digestive Diseases and Sciences 2002, 47:675-681.
32. Nakamura M., Haruma K., Kamada T., et al. Duodenogastric reflux is associated with antral metaplastic gastritis. Gastrointestinal Endoscopy 2001, 53:53-59.
33. Chen S.Y., Liu T.Y., Shun C.T., et al. Modification effects of GSTM1, GSTT1 and CYP2E1 polymorphisms on associations between raw salted food and incomplete intestinal metaplasia in a high-risk area of stomach cancer. International Journal of Cancer 2004, 108:606-612.
34. Leung W.K., Ng E.K., Chan W.Y., et al. Risk factors associated with the development of intestinal metaplasia in first-degree relatives of gastric cancer patients. Cancer Epidemiology, Biomarkers and Prevention 2005, 14:2982-2986.
35. Kim N., Park Y.S., Cho S.I., et al. Prevalence and risk factors of atrophic gastritis and intestinal metaplasia in a Korean population without significant gastroduodenal disease. Helicobacter 2008, 13:245-255.
36. Joo Y.E., Park H.K., Myung D.S., et al. Prevalence and risk factors of atrophic gastritis and intestinal metaplasia: a nationwide multicenter prospective study in Korea. Gut and Liver 2013, 7:303-310.
37. Boreiri M., Samadi F., Etemadi A., et al. Gastric cancer mortality in a high incidence area: long-term follow-up of Helicobacter pylori-related precancerous lesions in the general population. Archives of Iranian Medicine 2013, 16:343-347.
38. Fan Y.F., Wu Y.M., Liu H., et al. TLR4 polymorphisms associated with developing gastric pre-cancer lesions in a Chinese Han population. Human Immunology 2014, 75:176-181.
39. Nam J.H., Choi I.J., Kook M.C., et al. OLGA and OLGIM stage distribution according to age and Helicobacter pylori status in the Korean population. Helicobacter 2014, 19:81-89.
40. Mansour-Ghanaei F., Joukar F., Soati F., et al. Outcome of intestinal metaplasia in gastric biopsy of patients with dyspepsia in Guilan Province, North Iran. Asian Pacific Journal of Cancer Prevention 2013, 14:3549-3554.
41. Shousha S., Barrison I.G., El-Sayeed W., et al. A study of incidence and relationship of intestinal metaplasia of gastric antrum and gastric metaplasia of duodenum in patients with nonulcer dyspepsia. Digestive Diseases and Sciences 1984, 29:311-316.
42. Judd P.A. The ECP-EURONUT intestinal metaplasia study-lifestyle and dietary data. European Journal of Cancer Prevention 1994, 3:81-88.
43. de Vries A.C., Haringsma J., de Vries R.A., et al. The use of clinical, histologic, and serologic parameters to predict the intragastric extent of intestinal metaplasia: a recommendation for routine practice. Gastrointestinal Endoscopy 2009, 70:18-25.
44. Jedrychowski W., Popiela T., Drews M., et al. Effect of Helicobacter pylori infection, smoking and dietary habits on the occurrence of antrum intestinal metaplasia. Clinico-epidemiological study in Poland. Polish Journal of Pathology 1999, 50:289-295.
45. Russo A., Maconi G., Spinelli P., et al. Effect of lifestyle, smoking, and diet on development of intestinal metaplasia in H. pylori-positive subjects. American Journal of Gastroenterology 2001, 96:1402-1408.
46. Peleteiro B., Lunet N., Figueiredo C., et al. Smoking, Helicobacter pylori virulence, and type of intestinal metaplasia in Portuguese males. Cancer Epidemiology, Biomarkers and Prevention 2007, 16:322-326.
47. Koivisto T.T., Voutilainen M.E., Farkkila M.A. Effect of smoking on gastric histology in Helicobacter pylori-positive gastritis. Scandinavian Journal of Gastroenterology 2008, 43:1177-1183.
48. Gonzalez C.A., Pardo M.L., Liso J.M., et al. Gastric cancer occurrence in preneoplastic lesions: a long-term follow-up in a high-risk area in Spain. International Journal of Cancer 2010, 127:2654-2660.
49. Abadir A., Streutker C., Brezden-Masley C., et al. Intestinal metaplasia and the risk of gastric cancer in an immigrant Asian population. Clinical Medicine Insights: Gastroenterology 2012, 5:43-50.
50. Stemmermann G.N., Nomura A.M., Chyou P.H., et al. Impact of diet and smoking on risk of developing intestinal metaplasia of the stomach. Digestive Diseases and Sciences 1990, 35:433-438.
51. Fay M., Fennerty M.B., Emerson J., et al. Dietary habits and the risk of stomach cancer: a comparison study of patients with and without intestinal metaplasia. Gastroenterology Nursing 1994, 16:158-162.
52. Fontham E.T., Ruiz B., Perez A., et al. Determinants of Helicobacter pylori infection and chronic gastritis. American Journal of Gastroenterology 1995, 90:1094-1101.
53. Kato I., Vivas J., Plummer M., et al. Environmental factors in Helicobacter pylori-related gastric precancerous lesions in Venezuela. Cancer Epidemiology, Biomarkers and Prevention 2004, 13:468-476.
54. Chacaltana A., Rodriguez C., Urday C., et al. Preneoplastic gastric lesions and Helicobacter pylori in endoscopic detection and early diagnosis of gastric cancer in a population of a medium and high socio-economic level. Revista de Gastroenterologia del Peru 2009, 29:218-225.
55. Chacaltana Mendoza A., Soriano Alvarez C., Frisancho Velarde O. Associated risk factors in patients with gastric intestinal metaplasia with mild gastroduodenal disease. Is it always related to Helicobacter pylori infection?. Revista de Gastroenterologia del Peru 2012, 32:50-57.
56. Fraser A.G., Peng S.L., Jass J.R. Intestinal metaplasia subtypes and Helicobacter pylori infection: a comparison of ethnic groups in New Zealand. Journal of Gastroenterology and Hepatology 1998, 13:560-565.
57. Peleteiro B., Barros R., Carrilho C., et al. Determinants of gastric CDX2 expression: a study in Mozambique. European Journal of Cancer Prevention 2012, 21:532-540.
58. Kim J., Cho Y.A., Choi I.J., et al. Effects of interleukin-10 polymorphisms, Helicobacter pylori infection, and smoking on the risk of noncardia gastric cancer. PLOS ONE 2012, 7:e29643.
59. Marques-Silva L., Areia M., Elvas L., et al. Prevalence of gastric precancerous conditions: a systematic review and meta-analysis. European Journal of Gastroenterology and Hepatology 2014, 26:378-387.
60. Ng M., Freeman M.K., Fleming T.D., et al. Smoking prevalence and cigarette consumption in 187 countries, 1980-2012. Journal of the American Medical Association 2014, 311:183-192.
61. Freedman N.D., Leitzmann M.F., Hollenbeck A.R., et al. Cigarette smoking and subsequent risk of lung cancer in men and women: analysis of a prospective cohort study. Lancet Oncology 2008, 9:649-656.
62. Bain C., Feskanich D., Speizer F.E., et al. Lung cancer rates in men and women with comparable histories of smoking. Journal of the National Cancer Institute 2004, 96:826-834.
63. Kurata J.H., Nogawa A.N. Meta-analysis of risk factors for peptic ulcer, Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking. Journal of Clinical Gastroenterology 1997, 24:2-17.
64. Mahadeva S., Goh K.L. Epidemiology of functional dyspepsia: a global perspective. World Journal of Gastroenterology 2006, 12:2661-2666.
65. Tredaniel J., Boffetta P., Buiatti E., et al. Tobacco smoking and gastric cancer: review and meta-analysis. International Journal of Cancer 1997, 72:565-573.
66. Nishino Y., Inoue M., Tsuji I., et al. Tobacco smoking and gastric cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Japanese Journal of Clinical Oncology 2006, 36:800-807.
67. Sasazuki S., Sasaki S., Tsugane S. Cigarette smoking, alcohol consumption and subsequent gastric cancer risk by subsite and histologic type. International Journal of Cancer 2002, 101:560-566.
68. Inoue M., Tajima K., Yamamura Y., et al. Influence of habitual smoking on gastric cancer by histologic subtype. International Journal of Cancer 1999, 81:39-43.
69. Ye W., Ekstrom A.M., Hansson L.E., et al. Tobacco, alcohol and the risk of gastric cancer by sub-site and histologic type. International Journal of Cancer 1999, 83:223-229.
70. Hishida A., Matsuo K., Goto Y., et al. Smoking behavior and risk of Helicobacter pylori infection, gastric atrophy and gastric cancer in Japanese. Asian Pacific Journal of Cancer Prevention 2010, 11:669-673.